Kymera Therapeutics (KYMR) Income Statement (2019 - 2026)
Income Statement report data from Sep 30, 2019 to Mar 31, 2026 for Kymera Therapeutics (KYMR).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Sep 30, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | ||||||||||||||||||||||||||
Total Revenue | 34M (+1097.56%) | 2.87M (+3.99%) | 2.76M (-75.96%) | 11M (-48.05%) | 22M (+199.05%) | 7.39M (+97.59%) | 3.74M (-85.42%) | 26M (+149.27%) | 10M (-78.51%) | 48M (+912.47%) | 4.73M (-71.35%) | 17M (+74.34%) | 9.47M (-41.33%) | 16M (+69.01%) | 9.55M (-17.03%) | 12M (+19.65%) | 9.62M (-37.04%) | 15M (-24.88%) | 20M (+9.83%) | 19M (-0.96%) | 19M (+46.21%) | 13M (-11.98%) | 15M (+341.64%) | 3.29M (-4.08%) | 3.43M (+261.05%) | 950K |
Cost Of Revenue | 34M (+1097.56%) | 2.87M (+3.99%) | 2.76M (-75.96%) | 11M (-48.05%) | 22M (+199.05%) | 7.39M (+97.59%) | 3.74M (-85.42%) | 26M (+149.27%) | 10M (-86.91%) | 79M | - | - | - | 47M | - | - | - | - | - | - | - | - | - | - | - | - |
Costof Goods And Services Sold | 34M (+1097.56%) | 2.87M (+3.99%) | 2.76M (-75.96%) | 11M (-48.05%) | 22M (+199.05%) | 7.39M (+97.59%) | 3.74M (-85.42%) | 26M (+149.27%) | 10M (-86.91%) | 79M | - | - | - | 47M | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses | ||||||||||||||||||||||||||
Research And Development | 98M (+17.09%) | 84M (+13.15%) | 74M (-5.49%) | 78M (-2.33%) | 80M (+11.75%) | 72M (+18.89%) | 60M (+2.04%) | 59M (+21.26%) | 49M (-7.83%) | 53M (+10.08%) | 48M (+5.13%) | 46M (+8.38%) | 42M (-2.09%) | 43M (-1.71%) | 44M (+6.27%) | 41M (+14.89%) | 36M (-4.24%) | 38M (-2.04%) | 38M (+8.77%) | 35M (+35.67%) | 26M (+27.32%) | 20M (+29.21%) | 16M (+14.18%) | 14M (+14.03%) | 12M (+7.16%) | 11M |
Selling General And Administrative | 20M (+20.26%) | 17M (-2.36%) | 17M (-1.76%) | 18M (+8.48%) | 16M (-0.37%) | 16M (+5.63%) | 15M (-11.00%) | 17M (+20.88%) | 14M (+0.98%) | 14M (+0.78%) | 14M (-0.07%) | 14M (+12.41%) | 13M (+7.99%) | 12M (+10.23%) | 11M (-4.26%) | 11M (+3.96%) | 11M (-9.63%) | 12M (+10.03%) | 11M (+32.88%) | 8.03M (+35.87%) | 5.91M (+14.09%) | 5.18M (-24.27%) | 6.84M (+86.89%) | 3.66M (+42.97%) | 2.56M (+70.67%) | 1.50M |
Operating Expenses | 119M (+17.61%) | 101M (+5.75%) | 95M (-0.77%) | 96M (-0.52%) | 97M (+9.51%) | 88M (+16.20%) | 76M (-0.94%) | 77M (+12.42%) | 68M (+1.37%) | 67M (+7.97%) | 62M (+3.91%) | 60M (+9.33%) | 55M (+0.04%) | 55M (+0.62%) | 54M (+4.03%) | 52M (+12.37%) | 47M (-5.50%) | 49M (+0.61%) | 49M (+13.23%) | 43M (+35.71%) | 32M (+24.64%) | 26M (+13.04%) | 23M (+29.41%) | 17M (+19.07%) | 15M (+14.60%) | 13M |
Depreciation And Amortization | 2.02M (-18.22%) | 2.47M (+17.62%) | 2.10M (+23.53%) | 1.70M (-17.07%) | 2.05M (+1.99%) | 2.01M (+0.50%) | 2.00M (+5.26%) | 1.90M (+30.14%) | 1.46M (+64.04%) | 890K (-1.11%) | 900K (0.00%) | 900K (+2.27%) | 880K (+11.39%) | 790K (-1.25%) | 800K (+14.29%) | 700K (+1.45%) | 690K (-47.33%) | 1.31M | - | 600K (+22.45%) | 490K (+2.08%) | 480K (-4.00%) | 500K (+25.00%) | 400K (+2.56%) | 390K (+95.00%) | 200K |
Operating Income | ||||||||||||||||||||||||||
Operating Income | -84.15M (-14.04%) | -97.89M (+5.80%) | -92.52M (+9.41%) | -84.56M (+13.61%) | -74.43M (-7.83%) | -80.75M (+11.97%) | -72.12M (+41.63%) | -50.92M (-11.95%) | -57.83M (+199.48%) | -19.31M (-66.42%) | -57.51M (+32.57%) | -43.38M (-4.30%) | -45.33M (+17.34%) | -38.63M (-13.93%) | -44.88M (+9.97%) | -40.81M (+10.51%) | -36.93M (+8.65%) | -33.99M (+18.68%) | -28.64M (+15.81%) | -24.73M (+87.78%) | -13.17M (+3.05%) | -12.78M (+58.17%) | -8.08M (-43.06%) | -14.19M (+26.13%) | -11.25M (-5.14%) | -11.86M |
Ebit | -84.15M (-14.04%) | -97.89M (+5.80%) | -92.52M (+9.41%) | -84.56M (+13.61%) | -74.43M (-7.83%) | -80.75M (+11.97%) | -72.12M (+41.63%) | -50.92M (-11.95%) | -57.83M (+199.48%) | -19.31M (-66.42%) | -57.51M (+32.57%) | -43.38M (-4.30%) | -45.33M (+17.34%) | -38.63M (-13.93%) | -44.88M (+9.97%) | -40.81M (+10.51%) | -36.93M (+8.65%) | -33.99M (+18.68%) | -28.64M (+15.81%) | -24.73M (+87.78%) | -13.17M (+3.05%) | -12.78M (+58.17%) | -8.08M (-43.06%) | -14.19M (+26.13%) | -11.25M (-5.14%) | -11.86M |
EBITDA | -82.13M (-13.94%) | -95.43M (+5.54%) | -90.42M (+9.12%) | -82.86M (+14.48%) | -72.38M (-8.08%) | -78.74M (+12.29%) | -70.12M (+43.04%) | -49.02M (-13.04%) | -56.37M (+205.86%) | -18.43M (-67.44%) | -56.61M (+33.26%) | -42.48M (-4.43%) | -44.45M (+17.47%) | -37.84M (-14.16%) | -44.08M (+9.90%) | -40.11M (+10.65%) | -36.25M (+10.92%) | -32.68M (+14.11%) | -28.64M (+18.69%) | -24.13M (+90.30%) | -12.68M (+3.01%) | -12.31M (+62.40%) | -7.58M (-45.03%) | -13.79M (+26.98%) | -10.86M (-6.86%) | -11.66M |
Other Income / Expenses | ||||||||||||||||||||||||||
Other Non Operating Income | 15M (-60.79%) | 38M (+267.63%) | 10M (+30.35%) | 7.94M (-10.28%) | 8.85M (-76.57%) | 38M (+291.91%) | 9.64M (+8.80%) | 8.86M (-4.42%) | 9.27M (-50.08%) | 19M (+300.22%) | 4.64M (+1.31%) | 4.58M (+4.09%) | 4.40M (-31.78%) | 6.45M (+243.09%) | 1.88M (+241.82%) | 550K (+120.00%) | 250K (-19.35%) | 310K (+416.67%) | 60K (-14.29%) | 70K (-22.22%) | 90K (-87.32%) | 710K (+610.00%) | 100K (-50.00%) | 200K (-37.50%) | 320K (-27.27%) | 440K |
Net Income | ||||||||||||||||||||||||||
Income Before Tax | - | -311.35M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Income Tax Expense | - | - | - | - | - | - | - | - | - | -200.00K | 100K (0.00%) | 100K | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income From Continuing Operations | -69.23M (-20.41%) | -86.98M (+5.85%) | -82.17M (+7.26%) | -76.61M (+16.82%) | -65.58M (-7.31%) | -70.75M (+13.22%) | -62.49M (+48.57%) | -42.06M (-13.39%) | -48.56M (+237.93%) | -14.37M (-72.82%) | -52.87M (+36.26%) | -38.80M (-5.20%) | -40.93M (+17.41%) | -34.86M (-18.93%) | -43.00M (+6.81%) | -40.26M (+9.76%) | -36.68M (+8.20%) | -33.90M (+18.61%) | -28.58M (+15.90%) | -24.66M (+88.68%) | -13.07M (+2.99%) | -12.69M (+58.82%) | -7.99M (-42.89%) | -13.99M (+28.00%) | -10.93M (-4.29%) | -11.42M |
Net Income | -69.23M (-20.41%) | -86.98M (+5.85%) | -82.17M (+7.26%) | -76.61M (+16.82%) | -65.58M (-7.31%) | -70.75M (+13.22%) | -62.49M (+48.57%) | -42.06M (-13.39%) | -48.56M (+237.93%) | -14.37M (-72.82%) | -52.87M (+36.26%) | -38.80M (-5.20%) | -40.93M (+17.41%) | -34.86M (-18.93%) | -43.00M (+6.81%) | -40.26M (+9.76%) | -36.68M (+8.20%) | -33.90M (+18.61%) | -28.58M (+15.90%) | -24.66M (+88.68%) | -13.07M (+2.99%) | -12.69M (+58.82%) | -7.99M (-42.89%) | -13.99M (+28.00%) | -10.93M (-4.29%) | -11.42M |
Comprehensive Income Net Of Tax | -75.23M (-75.58%) | -308.07M (+280.57%) | -80.95M (+6.12%) | -76.28M (+18.91%) | -64.15M (-71.46%) | -224.79M (+284.52%) | -58.46M (+37.94%) | -42.38M (-14.87%) | -49.78M (-65.08%) | -142.56M (+175.85%) | -51.68M (+31.17%) | -39.40M (+0.97%) | -39.02M (-75.47%) | -159.10M (+254.11%) | -44.93M (+9.53%) | -41.02M (+4.54%) | -39.24M (-61.05%) | -100.75M (+250.68%) | -28.73M (+16.55%) | -24.65M (+90.20%) | -12.96M (-71.66%) | -45.73M (+459.05%) | -8.18M (-42.31%) | -14.18M (+32.28%) | -10.72M (-6.13%) | -11.42M |